Stephanie Greene

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Howard I. Scher, David Lu, Nicole A. Schreiber et al. · JAMA Oncology · 2016 · 627 citations · Full text

Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

Susan E. Logue, Eoghan P. McGrath, Patricia A. Cleary et al. · Nature Communications · 2018 · 283 citations · Full text

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Xia Sheng, Hatice Zeynep Nenseth, Su Qu et al. · Nature Communications · 2019 · 228 citations · Full text

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber et al. · Cancer Research · 2017 · 134 citations · Full text

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

Shannon L. Werner, Ryon P. Graf, Mark Landers et al. · Journal of Circulating Biomarkers · 2015 · 122 citations · Full text

Analytical Validation, Engineering, Pathology +18